Squamous-cell carcinoma of the tongue following therapy of rheumatoid arthritis with abatacept.

KEY CLINICAL MESSAGE: A patient affected by rheumatoid arthritis developed a squamous-cell carcinoma probably due to abatacept, according to Naranjo algorithm. The case describes this adverse reaction for the first time and highlights the need for additional studies to establish the long-term risk profile of abatacept.